Comments on the guidelines of the European Society of Cardiology Task Force on Pulmonary Embolism;Commento alle linee guida della Task Force sull'Embolia Polmonare della Società Europea di Cardiologia

Italian Heart Journal Supplement

Volumn 2, Issue 12, 2001, Pages 1342-1356

  Zonzin, Pietro ^a   Agnelli, Giancarlo ^a   Casazza, Franco ^a   Favretto, Giuseppe ^a   Giuntini, Carlo ^a   Morpurgo, Mario ^a   Dario Vizza, Carmine ^a  

^a Ospedale Civile   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; TINZAPARIN;

ALGORITHM; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; HUMAN; ITALY; LUNG EMBOLISM; MEDICAL SOCIETY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

ANGIOGRAPHY; ANTICOAGULANTS; CRITICAL ILLNESS; ECHOCARDIOGRAPHY; EMBOLECTOMY; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROBABILITY; PROSPECTIVE STUDIES; PUERPERAL DISORDERS; PULMONARY ARTERY; PULMONARY EMBOLISM; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; VENA CAVA FILTERS;

EID: 0035568942     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Linee guida per la diagnosi e il trattamento dell'embolia polmonare acuta
2. Iter diagnostici e terapeutici nell'embolia polmonare: Inchiesta nella Regione Veneto
3. L'epidemiologia della malattia tromboembolica venosa in Friuli Venezia Giulia
4. Pulmonary embolism: Epidemiology
5. Venous thromboembolism
6. Accuracy of clinical assessment in the diagnosis of pulmonary embolism
7. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study
8. Value of perfusion lung scan in the diagnosis of pulmonary embolism: Results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED)
9. Value of the ventilation-perfusion scan in acute pulmonary embolism: Results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
10. A proposito di scintigrafia polmonare nella diagnosi di embolia polmonare
11. Value of transthoracic echocardiography in the diagnosis of pulmonary embolism: Results of a prospective study in unselected patients
12. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction
13. Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate
14. Antithrombotic therapy for venous thromboembolism
15. The weight-based heparin dosing nomogram compared with a "standard care" nomogram: A randomized controlled trial
16. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease
17. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
18. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
19. Heparin and low-molecular weight heparin
20. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: International consensus on science
21. Death in pulmonary embolism
22. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism
23. Hemodynamic effects of bolus versus twohour infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial
24. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism
25. Thrombolytic therapy of pulmonary embolism. A comprehensive review of current evidence
26. Embolia polmonare massiva e controindicazioni alla trombolisi: Ruolo della trombectomia meccanica
27. Prevalence and prognostic significance of right-sided cardiac mobile thrombi in acute massive pulmonary embolism
28. Effectiveness of intravenous rtPA in the treatment of massive pulmonary embolism and right heart thromboembolism
29. Use of antithrombotic agents during pregnancy
30. Prevention of fatal postoperative pulmonary embolism by low-doses of heparin: An international multicenter trial
31. Economic analysis of low-dose heparin vs low-molecular weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery
32. Postoperative thromboembolism after day-case herniorrhaphy
33. Prevention of deep vein thrombosis by intermittent pneumatic compression of calf
34. A randomized controlled trial of a low-molecular weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery
35. Prevention of deep vein thrombosis following total hip replacement by low-molecular weight heparinoid
36. Thrombophlebitis following knee surgery
37. Venous thromboembolic disease after hip surgery: Risk factors, prophylaxis and diagnosis
38. Differences in mortality after fracture of hip: The East Anglian audit
39. VTE prophylaxis in gynecologic oncology: A prospective controlled trial of low-dose heparin
40. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis
41. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep vein thrombosis after gynecologic oncology surgery
42. Thromboembolic complication rate after radical retropubic prostatectomy: Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas
43. Low molecular weight heparin and radical prostatectomy: A prospective analysis of safety and side effects prostate cancer
44. A comparison of intermittent pneumatic compression of the calf and whole leg in preventing deep vein thrombosis in urological surgery
45. Incidence and prevention of deep venous thrombosis occurring late after general surgery: Randomised controlled study of prolonged thromboprophylaxis
46. Cost-effectiveness of prophylactic anticoagulation prolonged after hospital discharge following general surgery
47. Ardeparin sodium for extended out-of-hospital prophylaxis after total hip or knee replacement: A randomised, double blind, placebo controlled trial
48. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery
49. Anticoagulants and spinal-epidural anesthesia
50. Low molecular weight heparin: Biochemistry, pharmacology, perioperative prophylaxis regimens and guidelines for regional anesthetic management
51. Spinal and epidural hematoma and low molecular weight heparin
52. Prophylactic anticoagulant therapy in the prevention of calf vein thrombosis after myocardial infarction
53. A low molecular weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke: A randomised, double blind study
54. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
55. Randomised controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
56. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer
57. Prevention of venous thromboembolism
58. The legal implications of medical guidelines - A Task Force of the European Society of Cardiology